Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging
Authors not listed
Brigham and Women's Hospital · 2008
Abstract
The purpose of this study is determine if the iron chelator, desferrioxamine can increase blood levels of hypoxia-inducible transcription factor 1 (HIF-1 protein) and to see if there is a corresponding increase in blood flow to the brain.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2008). Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging. <em>Brigham and Women's Hospital</em>. https://clinicaltrials.gov/study/NCT01365104
Vancouver
Anonymous. Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging. Brigham and Women's Hospital. 2008.
BibTeX
@misc{anon2008Hypoxi,
title = {Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging},
author = {Anonymous},
journal = {Brigham and Women's Hospital},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brigham and Women's Hospital 2009
Open access · US-GOV
Hypoxia-inducible Transcription Factor 1 (HIF-1) in Vascular Aging
Poultry Science 2013
Open access · CC-BY
Supplemental glycine and threonine effects on performance, intestinal mucosa development, and nutrient utilization of growing broiler chickens
Montreal Heart Institute 2020
Open access · US-GOV
Characterization of the Increase and Distribution of Myocardial Blood Flow During Heat Exposure
Oregon Health and Science University 2014
Open access · US-GOV
Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline
Medicine 2026
Open access · OA
Routine CT-based hounsfield unit measurements as predictors of osteoporosis : A comparative analysis with DXA and development of a nomogram for clinical application
Drugs 2011
Citation only